Avita Enlists Sinopharm In ReCell Sales Ramp-Up
This article was originally published in Clinica
Executive Summary
Avita Medical has teamed up with China’s largest medical and healthcare group, to help it penetrate further into what it believes is the most strategic market – alongside the US – for its autologous cell-based therapy for advanced woundcare and skin defects.